Skip to main content

Advertisement

Log in

Animal models of psoriasis and psoriatic arthritis: An update

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Psoriasis is a chronic inflammatory skin disorder characterized by accelerated growth and altered differentiation of keratinocytes and angiogenesis with marked ectasia of blood vessels. It develops through interactions between the skin and immune system mediated by T cells, dendritic cells, and inflammatory cytokines. The understanding of the cellular and molecular alterations underlying the disease has advanced, yet the majority of factors leading to the initiation and maintenance of disease remain elusive. Researchers have attempted to reproduce psoriasis in genetically modified and xenotransplantation mouse models to gain insight into its pathogenesis, and they are beginning to use these models to test new therapeutic agents and define mechanisms of action. Every mouse model has strengths and weaknesses, with room for improvement. Still, these models will accelerate knowledge of psoriasis pathogenesis and aid in the development of new therapeutics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Nickoloff BJ, Nestle FO: Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 2004, 113:1664–1675.

    Article  PubMed  CAS  Google Scholar 

  2. Davidson A, Diamond B: Autoimmune diseases. N Engl J Med 2001, 345:340 -350.

    Article  PubMed  CAS  Google Scholar 

  3. Nestle FO, Turka LA, Nickoloff BJ: Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. J Clin Invest 1994, 94:202–209.

    PubMed  CAS  Google Scholar 

  4. Krueger GG, Bergstresser PR, Lowe NJ, et al.: Psoriasis. J Am Acad Dermatol 1984, 11:937–947.

    PubMed  CAS  Google Scholar 

  5. Barker JN: The pathophysiology of psoriasis. Lancet 1991, 338:227–230.

    Article  PubMed  CAS  Google Scholar 

  6. Ackermann L, Harvima IT, Pelkonen J, et al.: Mast cells in psoriatic skin are strongly positive for interferon-gamma. Br J Dermatol 1991, 140:624–633.

    Article  Google Scholar 

  7. Lowe PM, Lee ML, Jackson CJ, et al.: The endothelium in psoriasis. Br J Dermatol 1995, 132:497–505.

    Article  PubMed  CAS  Google Scholar 

  8. Nickoloff BJ: The immunologic and genetic basis of psoriasis. Arch Dermatol 1999, 135:1104–1110.

    Article  PubMed  CAS  Google Scholar 

  9. Gottlieb AB: Immunologic mechanisms in psoriasis. J Am Acad Dermatol 1988, 18:1376–1380.

    Article  PubMed  CAS  Google Scholar 

  10. Chang JC, Smith LR, Froning KJ, et al.: Persistence of T-cell clones in psoriatic lesions. Arch Dermatol 1997, 133:703–708.

    Article  PubMed  CAS  Google Scholar 

  11. Vollmer S, Menssen A, Prinz JC: Dominant lesional T cell receptor rearrangements persist in relapsing psoriasis but are absent from nonlesional skin: evidence for a stable antigen-specific pathogenic T cell response in psoriasis vulgaris. J Invest Dermatol 2001, 117:1296–1301.

    Article  PubMed  CAS  Google Scholar 

  12. Wrone-Smith T, Nickoloff BJ: Dermal injection of immunocytes induces psoriasis. J Clin Invest 1996, 98:1878–1887.

    PubMed  CAS  Google Scholar 

  13. Boehncke WH, Dressel D, Zollner TM, Kaufmann R: Pulling the trigger on psoriasis. Nature 1996, 379:777.

    Article  PubMed  CAS  Google Scholar 

  14. Boyman O, Hefti HP, Conrad C, et al.: Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factoralpha. J Exp Med 2004, 199:731–736. Xenotransplantation psoriasis model with spontaneous development of psoriasis in a T-cell and TNF-α dependent manner.

    Article  PubMed  CAS  Google Scholar 

  15. Zenz R, Eferl R, Kenner L, et al.: Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 2005, 437:369–375. Epidermal deletion of AP-1 proteins leads to psoriasiform skin inflammation and arthritis. Arthritis lesions are dependent on T cells and TNFR signaling.

    Article  PubMed  CAS  Google Scholar 

  16. Schon MP: Animal models of psoriasis—what can we learn from them? J Invest Dermatol 1999, 112:405–410.

    Article  PubMed  CAS  Google Scholar 

  17. Haider AS, Duculan J, Whynot JA, Krueger JG: Increased JunB mRNA and protein expression in psoriasis vulgaris lesions. J Invest Dermatol 2006, 126:912–914.

    Article  PubMed  CAS  Google Scholar 

  18. Gottlieb SL, Gilleaudeau P, Johnson R, et al.: Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1995, 1:442–447.

    Article  PubMed  CAS  Google Scholar 

  19. Sano S, Chan KS, Carbajal S, et al.: Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 2005, 11:43–49. Expression of activated STAT3 in mouse epidermis leads to T cell dependent psoriasiform skin inflammation showing that keratinocytes and immune cells interdependently participate in psoriasis pathogenesis.

    Article  PubMed  CAS  Google Scholar 

  20. Nickoloff BJ, Wrone-Smith T: Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol 1999, 155:145–158.

    PubMed  CAS  Google Scholar 

  21. Nickoloff BJ, Bonish B, Huang BB, Porcelli SA: Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system. J Dermatol Sci 2000, 24:212–225.

    Article  PubMed  CAS  Google Scholar 

  22. Gilhar A, Ullmann Y, Kerner H, et al.: Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors. J Invest Dermatol 2002, 119:384–391.

    Article  PubMed  CAS  Google Scholar 

  23. Boyman O, Conrad C, Dudli C, et al.: Activation of dendritic antigen-presenting cells expressing common heat shock protein receptor CD91 during induction of psoriasis. Br J Dermatol 2005, 152:1211–1218.

    Article  PubMed  CAS  Google Scholar 

  24. Nestle FO, Conrad C, Tun-Kyi A, et al.: Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 2005, 202:135–143. IFN-α produced by plasmacytoid predendritic cells is identified as a major innate driver of the inflammatory disease process in psoriasis.

    Article  PubMed  CAS  Google Scholar 

  25. Blessing M, Schirmacher P, Kaiser S: Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions. J Cell Biol 1996, 135:227–239.

    Article  PubMed  CAS  Google Scholar 

  26. Hammer RE, Maika SD, Richardson JA, et al.: Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLAB27- associated human disorders. Cell 1990, 63:1099–1112.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Curdin Conrad MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Conrad, C., Nestle, F.O. Animal models of psoriasis and psoriatic arthritis: An update. Curr Rheumatol Rep 8, 342–347 (2006). https://doi.org/10.1007/s11926-006-0063-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-006-0063-x

Keywords

Navigation